Mobile

A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Safety and Efficacy of Subcutaneous Bioresorbable Implants of CUV1647 for the Prophylactic Treatment of Pre-C...

Update Il y a 4 ans
Reference: EUCTR2007-007015-89

A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Safety and Efficacy of Subcutaneous Bioresorbable Implants of CUV1647 for the Prophylactic Treatment of Pre-Cancerous Skin Lesions of the Head, Forearms and Hands in Immune Compromised, Organ Transplant Patients

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

- To determine the effect of CUV1647 administered from slow release subcutaneous implants on the number of actinic keratoses (AKs) on the head, forearms and back of hands during a 24 month test period.

Inclusion criteria

  • Pre-cancerous skin lesions

Links